Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05361668 |
Recruitment Status :
Active, not recruiting
First Posted : May 5, 2022
Last Update Posted : February 1, 2024
|
Sponsor:
Crinetics Pharmaceuticals Inc.
Information provided by (Responsible Party):
Crinetics Pharmaceuticals Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | April 2024 |
Estimated Study Completion Date : | February 2026 |